In pre-market trading hours on Thursday, the premier physician-led weight loss and metabolic health solutions company, ReShape Lifesciences Inc. (RSLS) rose 14.44% to $4.12. ReShape Lifesciences traded 1.93 million shares, which was below the daily average of 3.04 million shares over the past 100 days. RSLS stock finished the last trading session at $3.60, down -3.23%. RSLS stock has slipped -5.26% over the past five sessions, while it saw a loss of -13.88% over a month. RSLS stock is gaining traction before release of its quarterly results.
Is RSLS is set to release its financials soon?
ReShape Lifesciences is America’s leading weight-loss and metabolic-health-solutions firm, with a comprehensive portfolio of tried-and-true products and services for managing and treating obesity and metabolic illness. The FDA-approved Lap-Band Program from RSLS is a minimally invasive, long-term obesity therapy that is an alternative to more invasive surgical stapling treatments like gastric bypass or sleeve gastrectomy. The ReShape Vest System is a minimally invasive, laparoscopically implanted medical device that wraps around the stomach, simulating the gastric volume reduction effect of traditional weight-loss surgery outside of the United States.
The ReShape Lifesciences Vest System helps obese and severely obese people lose weight quickly without permanently altering their morphology. RSLS Care is a virtual weight-management program that encourages all weight-loss patients to make lifestyle adjustments guided by board-certified health coaches in order to help them maintain their weight reduction over time. ReShape Marketplace, which was just established, is an online collection of high-quality wellness goods designed for all customers to help them reach their health objectives.
Before the financial markets open today, ReShape Lifesciences (RSLS) will announce its second quarter financial results. RSLS plans to provide a business update to its shareholders as well as announce its key events and results from the second quarter. Following the announcement of the financial results today, management will host a webinar to discuss RSLS’ financial performance. The link to the webinar will be available on the RSLS website’s Investor Relations page.
With the launch of ReShape Marketplace, RSLS extends its reimbursed weight loss telehealth service, called reshape care, to include any prescribed weight loss therapy. Consumers with ReShape Marketplace have access to a collection of innovative, affordable, and useful wellness products aimed at aiding their recovery from stress, exercise, sleep disorders, and nutritional deficiencies.
How does ReShape Lifesciences expect to perform this quarter?
As part of its general health services and virtual healthcare offerings, e-commerce is likely to add to the RSLS’ financial performance in the current quarter and to help people achieve their nutrition activity and exercise goals. In addition to demonstrating continued commitment to the physician-led weight-loss market, ReShape LifeSciences (RSLS) continues to establish itself as the premier provider of personalized weight-loss pathways, products, and services that support individual health and wellness goals.
